• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

采用琼脂扩散法对短帚霉菌株进行体外抗真菌药敏试验。

In vitro antifungal susceptibility testing of Scopulariopsis brevicaulis strains using agar diffusion method.

作者信息

Skóra Magdalena, Macura Anna B

机构信息

Department of Mycology, Jagiellonian University Medical College, 18 Czysta Street, 31-121 Kraków, Poland.

出版信息

Wiad Parazytol. 2011;57(2):111-6.

PMID:21682097
Abstract

The genus Scopulariopsis is a common soil saprotroph and has been isolated from air, organic waste and also from plant, animal and human tissues. Scopulariopsis has mainly been associated in humans with superficial mycoses, but it has also been described as the cause of subcutaneous and invasive infections. The most common aetiological agent of infections in humans is Scopulariopsis brevicaulis. This species has been reported to be resistant in vitro to broad-spectrum antifungal agents available today. The aim of the study was to establish in vitro antifungal susceptibility of 35 S. brevicaulis strains against amphotericin B (AMB), flucytosine (FC), caspofungin (CAS), terbinafine (TER), ciclopirox (CIC), voriconazole (VOR), clotrimazole (CTR), miconazole (MCZ), econazole (ECO), ketoconazole (KET), itraconazole (ITR), and fluconazole (FLU). Antifungal susceptibility tests were evaluated by an agar diffusion method (Neo-Sensitabs, Rosco, Denmark). AMB, FC, CAS, ITR and FLU showed no antifungal activity against S. brevicaulis. TER, CIC, CTR, KET, VOR, ECO, and MCZ revealed inhibitory activity for S. brevicaulis, but it varied for each of the drugs. The best antifungal effect was observed for TER and CIC. All isolates had large inhibition zones for TER and CIC. CTR was also inhibitory for all tested S. brevicaulis isolates, but the diameters of inhibition zones were smaller than for TER and CIC. Nearly 89% isolates showed inhibition zones for KET and the mean diameter of the inhibition zone was comparable to CTR. The least antifungal activity exhibited VQR, ECO and MCZ. Because of the multiresistance of S. brevicaulis, infections due to this species may not respond to particular antifungal treatment and other therapeutic approaches should be considered, e.g., combined therapy and/or surgery.

摘要

帚霉属是一种常见的土壤腐生菌,已从空气、有机废物以及植物、动物和人体组织中分离出来。帚霉在人类中主要与浅表真菌病相关,但也被描述为皮下和侵袭性感染的病因。人类感染最常见的病原体是短帚霉。据报道,该菌种在体外对目前可用的广谱抗真菌药物具有抗性。本研究的目的是确定35株短帚霉菌株对两性霉素B(AMB)、氟胞嘧啶(FC)、卡泊芬净(CAS)、特比萘芬(TER)、环吡酮(CIC)、伏立康唑(VOR)、克霉唑(CTR)、咪康唑(MCZ)、益康唑(ECO)、酮康唑(KET)、伊曲康唑(ITR)和氟康唑(FLU)的体外抗真菌敏感性。采用琼脂扩散法(丹麦Rosco公司的Neo - Sensitabs)评估抗真菌药敏试验。AMB、FC、CAS、ITR和FLU对短帚霉无抗真菌活性。TER、CIC、CTR、KET、VOR、ECO和MCZ对短帚霉显示出抑制活性,但每种药物的活性有所不同。观察到TER和CIC的抗真菌效果最佳。所有分离株对TER和CIC都有较大的抑菌圈。CTR对所有测试的短帚霉分离株也有抑制作用,但抑菌圈直径小于TER和CIC。近89%的分离株对KET有抑菌圈,抑菌圈平均直径与CTR相当。VOR、ECO和MCZ表现出的抗真菌活性最低。由于短帚霉具有多重耐药性,该菌种引起的感染可能对特定的抗真菌治疗无反应,应考虑其他治疗方法,如联合治疗和/或手术。

相似文献

1
In vitro antifungal susceptibility testing of Scopulariopsis brevicaulis strains using agar diffusion method.采用琼脂扩散法对短帚霉菌株进行体外抗真菌药敏试验。
Wiad Parazytol. 2011;57(2):111-6.
2
In vitro antifungal susceptibility of Scopulariopsis brevicaulis isolates.短帚霉分离株的体外抗真菌药敏试验
Med Mycol. 2014 Oct;52(7):723-7. doi: 10.1093/mmy/myu039. Epub 2014 Jul 21.
3
[Antifungal susceptibility of clinical isolates of Scopulariopsis species].[帚霉属临床分离株的抗真菌药敏性]
Rev Esp Quimioter. 2014 Mar;27(1):17-21.
4
In vitro antifungal activity of sertaconazole compared with nine other drugs against 250 clinical isolates of dermatophytes and Scopulariopsis brevicaulis.与其他九种药物相比,舍他康唑对250株皮肤癣菌和短帚霉临床分离株的体外抗真菌活性。
Chemotherapy. 2004 Dec;50(6):308-13. doi: 10.1159/000082631. Epub 2004 Dec 8.
5
[Is amphotericin B active against dermatophytes and Scopulariopsis brevicaulis?].两性霉素B对皮肤癣菌和短帚霉是否有活性?
Rev Esp Quimioter. 2004 Sep;17(3):244-9.
6
In vitro activities of a wide panel of antifungal drugs against various Scopulariopsis and Microascus species.多种抗真菌药物对不同种类帚霉属和小囊菌属真菌的体外活性。
Antimicrob Agents Chemother. 2015 Sep;59(9):5827-9. doi: 10.1128/AAC.00978-15. Epub 2015 Jun 22.
7
[In vitro antifungal susceptibility profile of Scopulariopsis brevicaulis isolated from onychomycosis].[从甲癣分离出的短帚霉的体外抗真菌药敏谱]
Rev Esp Quimioter. 2015 Aug;28(4):210-3.
8
In vitro activity of voriconazole against dermatophytes, Scopulariopsis brevicaulis and other opportunistic fungi as agents of onychomycosis.伏立康唑对皮肤癣菌、短帚霉及其他引起甲真菌病的机会性真菌的体外活性。
Int J Antimicrob Agents. 2007 Aug;30(2):157-61. doi: 10.1016/j.ijantimicag.2007.04.004. Epub 2007 Jun 6.
9
Terbinafine susceptibility patterns for onychomycosis-causative dermatophytes and Scopulariopsis brevicaulis.特比萘芬对甲癣致病皮肤癣菌和短帚霉的药敏模式。
Int J Antimicrob Agents. 2008 Jun;31(6):540-3. doi: 10.1016/j.ijantimicag.2008.01.023. Epub 2008 Mar 25.
10
[In vitro antifungal activity of voriconazole against dermatophytes and superficial isolates of Scopulariopsis brevicaulis].伏立康唑对皮肤癣菌和短帚霉浅表分离株的体外抗真菌活性
Rev Iberoam Micol. 2005 Jun;22(2):110-3. doi: 10.1016/s1130-1406(05)70019-x.

引用本文的文献

1
In vitro activities of a wide panel of antifungal drugs against various Scopulariopsis and Microascus species.多种抗真菌药物对不同种类帚霉属和小囊菌属真菌的体外活性。
Antimicrob Agents Chemother. 2015 Sep;59(9):5827-9. doi: 10.1128/AAC.00978-15. Epub 2015 Jun 22.